213 related articles for article (PubMed ID: 11937546)
1. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide.
Hu J; Jacinto R; McCall C; Li L
J Immunol; 2002 Apr; 168(8):3910-4. PubMed ID: 11937546
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN
J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239
[TBL] [Abstract][Full Text] [Related]
3. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.
Yang RB; Mark MR; Gurney AL; Godowski PJ
J Immunol; 1999 Jul; 163(2):639-43. PubMed ID: 10395652
[TBL] [Abstract][Full Text] [Related]
4. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.
Asehnoune K; Strassheim D; Mitra S; Kim JY; Abraham E
J Immunol; 2004 Feb; 172(4):2522-9. PubMed ID: 14764725
[TBL] [Abstract][Full Text] [Related]
5. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
6. Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin.
Moors MA; Li L; Mizel SB
Infect Immun; 2001 Jul; 69(7):4424-9. PubMed ID: 11401982
[TBL] [Abstract][Full Text] [Related]
7. Dual receptors and distinct pathways mediate interleukin-1 receptor-associated kinase degradation in response to lipopolysaccharide. Involvement of CD14/TLR4, CR3, and phosphatidylinositol 3-kinase.
Noubir S; Hmama Z; Reiner NE
J Biol Chem; 2004 Jun; 279(24):25189-95. PubMed ID: 15069085
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase.
Jacinto R; Hartung T; McCall C; Li L
J Immunol; 2002 Jun; 168(12):6136-41. PubMed ID: 12055225
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells.
Li X; Tupper JC; Bannerman DD; Winn RK; Rhodes CJ; Harlan JM
Infect Immun; 2003 Aug; 71(8):4414-20. PubMed ID: 12874320
[TBL] [Abstract][Full Text] [Related]
10. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4.
del Fresno C; Otero K; Gómez-García L; González-León MC; Soler-Ranger L; Fuentes-Prior P; Escoll P; Baos R; Caveda L; García F; Arnalich F; López-Collazo E
J Immunol; 2005 Mar; 174(5):3032-40. PubMed ID: 15728517
[TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription.
Chen LY; Zuraw BL; Liu FT; Huang S; Pan ZK
J Immunol; 2002 Oct; 169(7):3934-9. PubMed ID: 12244193
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
Janssens S; Burns K; Tschopp J; Beyaert R
Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
[TBL] [Abstract][Full Text] [Related]
13. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
Rao N; Nguyen S; Ngo K; Fung-Leung WP
Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
[TBL] [Abstract][Full Text] [Related]
14. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression.
Yeo SJ; Yoon JG; Hong SC; Yi AK
J Immunol; 2003 Jan; 170(2):1052-61. PubMed ID: 12517973
[TBL] [Abstract][Full Text] [Related]
15. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
17. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
Qin J; Qian Y; Yao J; Grace C; Li X
J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
[TBL] [Abstract][Full Text] [Related]
18. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells.
Li L; Cousart S; Hu J; McCall CE
J Biol Chem; 2000 Jul; 275(30):23340-5. PubMed ID: 10811644
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1.
Siedlar M; Frankenberger M; Benkhart E; Espevik T; Quirling M; Brand K; Zembala M; Ziegler-Heitbrock L
J Immunol; 2004 Aug; 173(4):2736-45. PubMed ID: 15294992
[TBL] [Abstract][Full Text] [Related]
20. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members.
Janssens S; Beyaert R
Mol Cell; 2003 Feb; 11(2):293-302. PubMed ID: 12620219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
